Indeed, R406 induced hypertension, inhibited VEGF-induced hypotension, and blocked KDR phosphorylation in vivo in preclinical models [52], providing indirect but compelling evidence that hypertensive effect of R406 in the clinic may be mediated through KDR. This evidence concerns the gene VEGFA and Hypertension.